Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Covalent inhibitors: An ambitious approach for the discovery of newer oncotherapeutics
Rameshwar S. Cheke, Prashant S. Kharkar
Drug Development Research (2023) Vol. 85, Iss. 1
Open Access | Times Cited: 12

Showing 12 citing articles:

Kinase Inhibitors and Kinase-Targeted Cancer Therapies: Recent Advances and Future Perspectives
Jiahao Li, Gong Chen, Haiting Zhou, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 10, pp. 5489-5489
Open Access | Times Cited: 21
An Antiherpesviral Host-Directed Strategy Based on CDK7 Covalently Binding Drugs: Target-Selective, Picomolar-Dose, Cross-Virus Reactivity
DongHoon Yu, Sabrina Wagner, Martin Schütz, et al.
Pharmaceutics (2024) Vol. 16, Iss. 2, pp. 158-158
Open Access | Times Cited: 6
Synthesis and antitumor effects of novel betulinic acid derivatives bearing electrophilic moieties
Sen Cai, Xiuhan Guo, Haozhe Yang, et al.
Bioorganic & Medicinal Chemistry (2025) Vol. 119, pp. 118062-118062
Closed Access
Small molecule compounds targeting G9a/GLP: Recent advances and perspectives
Qiangsheng Zhang, Li Lu, Siyan Li, et al.
European Journal of Medicinal Chemistry (2025), pp. 117525-117525
Closed Access
Psoralen alleviates acute lung injury by covalently targeting Cys106 of HMGB1 in macrophages to inhibit inflammatory responses
Yixu Wang, Jin Zhang, Sihan Xu, et al.
Phytomedicine (2025), pp. 156807-156807
Closed Access
Biology and pharmacological inhibition of homeodomain-interacting protein kinases
Adam Štefek, Kamil Paruch
Frontiers in Chemical Biology (2025) Vol. 4
Open Access
Advancements, challenges, and future frontiers in covalent inhibitors and covalent drugs: A review
Muhammad Salman Hameed, Hongxuan Cao, Li Guo, et al.
European Journal of Medicinal Chemistry Reports (2024), pp. 100217-100217
Open Access | Times Cited: 2
Lysine-Targeted Covalent Inhibitors of PI3Kδ Synthesis and Screening by In Situ Interaction Upgradation
Bo Yuan, Yifan Feng, Mengyan Ma, et al.
Journal of Medicinal Chemistry (2024)
Closed Access | Times Cited: 2
Targeting fusion oncoproteins in childhood cancers: challenges and future opportunities for developing therapeutics
Sharad K. Verma, Keren L. Witkin, Anu Sharman, et al.
JNCI Journal of the National Cancer Institute (2024) Vol. 116, Iss. 7, pp. 1012-1018
Open Access | Times Cited: 1
Exploring the landscape of post-translational modification in drug discovery
Yuhao Cao, Tianyi Yu, Zhiguang Zhu, et al.
Pharmacology & Therapeutics (2024) Vol. 265, pp. 108749-108749
Closed Access | Times Cited: 1
Global Profiling Lysine Reactivity and Ligandability with Oxidant‐Triggered Bioconjugation Chemistry
Mengya Zhou, Shengrong Li, Yi Tan, et al.
Angewandte Chemie International Edition (2024)
Closed Access
Global Profiling Lysine Reactivity and Ligandability with Oxidant‐Triggered Bioconjugation Chemistry
Mengya Zhou, Shengrong Li, Yi Jiun Tan, et al.
Angewandte Chemie (2024)
Closed Access
Page 1

Scroll to top